Indian Agency Fines Ranbaxy Unit For Late Lab Report After Patient Death
This article was originally published in PharmAsia News
Executive Summary
An Indian agency ordered Ranbaxy Laboratories to pay a fine of $1,165 to an Indian family for failing to issue a test report on time. The fine was ordered by the Delhi State Consumer Disputes Redressal Commission against Specialty Ranbaxy to pay the family after a member died awaiting a crucial medical test needed before surgery. The court said Ranbaxy took 25 days to produce the report, after the patient had died. Conflicting pathological laboratory results led to the request from Specialty Ranbaxy's lab. (Click here for more
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.